Editorial: Genome editing applications of CRISPR/Cas9 in metabolic diseases, hormonal system and cancer research.
作者信息
Liu Pengpeng, Huang Lei, Song Chun-Qing
机构信息
Molecular, Cell and Cancer Biology (MCCB), 1University of Massachusetts Medical School, Worcester, MA, United States.
Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.
出版信息
Front Endocrinol (Lausanne). 2023 Aug 7;14:1256966. doi: 10.3389/fendo.2023.1256966. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Genome editing applications of CRISPR/Cas9 in metabolic diseases, hormonal system and cancer research.社论：CRISPR/Cas9在代谢疾病、激素系统及癌症研究中的基因组编辑应用
Front Endocrinol (Lausanne). 2023 Aug 7;14:1256966. doi: 10.3389/fendo.2023.1256966. eCollection 2023.
2
CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.CRISPR-cas9 基因组编辑递送系统用于靶向癌症治疗。
Life Sci. 2021 Feb 15;267:118969. doi: 10.1016/j.lfs.2020.118969. Epub 2020 Dec 29.
3
The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.CRISPR-Cas9 基因组编辑工具在癌症免疫治疗中的应用。
Brief Funct Genomics. 2019 Mar 22;18(2):129-132. doi: 10.1093/bfgp/ely011.
4
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.CRISPR/Cas9 基因编辑在癌症中的当前应用和未来展望。
Mol Cancer. 2022 Feb 21;21(1):57. doi: 10.1186/s12943-022-01518-8.
5
CRISPR-Cas9 therapies in experimental mouse models of cancer.CRISPR-Cas9 疗法在癌症实验小鼠模型中的应用。
Future Oncol. 2018 Aug;14(20):2083-2095. doi: 10.2217/fon-2018-0028. Epub 2018 Jul 20.
6
Online Databases of Genome Editing in Cardiovascular and Metabolic Diseases.心血管和代谢疾病基因编辑在线数据库
Adv Exp Med Biol. 2023;1396:19-33. doi: 10.1007/978-981-19-5642-3_2.
7
Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?基因组编辑与癌症：CRISPR/Cas9 的研究进展到哪了？
Biomed Pharmacother. 2022 Jun;150:113011. doi: 10.1016/j.biopha.2022.113011. Epub 2022 Apr 25.
8
Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.CRISPR/Cas9 基因编辑技术在癌症治疗研究中的应用。
Clin Genet. 2020 Jan;97(1):73-88. doi: 10.1111/cge.13589. Epub 2019 Jul 10.
9
Applications and advances of CRISPR-Cas9 in cancer immunotherapy.CRISPR-Cas9 在癌症免疫治疗中的应用与进展。
J Med Genet. 2019 Jan;56(1):4-9. doi: 10.1136/jmedgenet-2018-105422. Epub 2018 Jul 3.
10
CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.CRISPR-Cas9，癌症治疗有前途的治疗工具：综述。
Protein Pept Lett. 2020;27(10):931-944. doi: 10.2174/0929866527666200407112432.
引用本文的文献
1
CRISPR-Assisted Probiotic and In Situ Engineering of Gut Microbiota: A Prospect to Modification of Metabolic Disorders.CRISPR辅助的益生菌与肠道微生物群原位工程：改善代谢紊乱的前景
Probiotics Antimicrob Proteins. 2025 May 16. doi: 10.1007/s12602-025-10561-y.
2
Targeting exercise-related genes and placental growth factor for therapeutic development in head and neck squamous cell carcinoma.靶向与运动相关的基因和胎盘生长因子用于头颈部鳞状细胞癌的治疗开发。
Front Pharmacol. 2024 Oct 4;15:1476076. doi: 10.3389/fphar.2024.1476076. eCollection 2024.
3
Investigating the therapeutic potential of hesperidin targeting CRISP2 in intervertebral disc degeneration and cancer risk mitigation.研究橙皮苷靶向CRISP2在椎间盘退变和降低癌症风险方面的治疗潜力。
Front Pharmacol. 2024 Aug 29;15:1447152. doi: 10.3389/fphar.2024.1447152. eCollection 2024.
4
Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies.精准行动：成簇规律间隔短回文重复序列/CRISPR相关蛋白在基因治疗中的作用
Vaccines (Basel). 2024 Jun 7;12(6):636. doi: 10.3390/vaccines12060636.
本文引用的文献
1
CRISPR/Cas9/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression.CRISPR/Cas9/sgHMGA2@聚多巴胺纳米系统是针对高表达HMGA2的胃癌的潜在有效基因编辑疗法。
Front Oncol. 2022 Sep 2;12:978533. doi: 10.3389/fonc.2022.978533. eCollection 2022.
2
Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.基于 CRISPR/Cas9 的基因编辑技术在癌症基础研究、诊断和治疗中的应用。
Mol Cancer. 2021 Oct 1;20(1):126. doi: 10.1186/s12943-021-01431-6.
3
Highly efficient therapeutic gene editing of human hematopoietic stem cells.高效的人类造血干细胞治疗性基因编辑。
Nat Med. 2019 May;25(5):776-783. doi: 10.1038/s41591-019-0401-y. Epub 2019 Mar 25.
4
Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins.使用装载 Cas9-sgRNA 核糖核蛋白的病毒衍生的 Nanoblades 在原代细胞和体内进行基因组编辑。
Nat Commun. 2019 Jan 3;10(1):45. doi: 10.1038/s41467-018-07845-z.
5
Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer.IFT88 功能丧失决定甲状腺癌的代谢表型。
Oncogene. 2018 Aug;37(32):4455-4474. doi: 10.1038/s41388-018-0211-6. Epub 2018 May 10.
6
Mapping the genomic landscape of CRISPR-Cas9 cleavage.绘制 CRISPR-Cas9 切割的基因组图谱。
Nat Methods. 2017 Jun;14(6):600-606. doi: 10.1038/nmeth.4284. Epub 2017 May 1.
7
Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease.利用 CRISPR/Cas9 进行体细胞基因组编辑可产生并纠正代谢疾病。
Sci Rep. 2017 Mar 16;7:44624. doi: 10.1038/srep44624.
8
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.Cas9在CRISPR-Cas适应过程中指定功能性病毒靶点。
Nature. 2015 Mar 12;519(7542):199-202. doi: 10.1038/nature14245. Epub 2015 Feb 18.
9
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.CRISPR RNA 引导的内切酶 Cas9 对 DNA 的检测。
Nature. 2014 Mar 6;507(7490):62-7. doi: 10.1038/nature13011. Epub 2014 Jan 29.
10
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.Cas9-crRNA 核糖核蛋白复合物介导细菌适应性免疫中的特异性 DNA 切割。
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86. doi: 10.1073/pnas.1208507109. Epub 2012 Sep 4.
Zotero 插件